Anna Cariello
Ravenna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 05, 2025
Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practice.
Journal: Frontiers in oncology
Published: September 25, 2024
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.
Journal: Cancer treatment reviews
Published: June 21, 2024
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 14, 2023
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Journal: Frontiers in oncology
Published: January 27, 2023
Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 30, 2020
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 12, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026